Anticorps Polyclonal de lapin anti-ZFP64
ZFP64 Polyclonal Antibody for WB, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, rat, souris
Applications
WB, IF, ChIP, ELISA
Conjugaison
Non conjugué
N° de cat : 17187-1-AP
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en WB | tissu splénique de souris, cellules HEK-293 |
Dilution recommandée
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Applications publiées
| WB | See 1 publications below |
| IF | See 1 publications below |
| ChIP | See 3 publications below |
Informations sur le produit
17187-1-AP cible ZFP64 dans les applications de WB, IF, ChIP, ELISA et montre une réactivité avec des échantillons Humain, rat, souris
| Réactivité | Humain, rat, souris |
| Réactivité citée | Humain, souris |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Polyclonal |
| Type | Anticorps |
| Immunogène | ZFP64 Protéine recombinante Ag10971 |
| Nom complet | zinc finger protein 64 homolog (mouse) |
| Masse moléculaire calculée | 681 aa, 75 kDa |
| Poids moléculaire observé | 70 kDa |
| Numéro d’acquisition GenBank | BC041622 |
| Symbole du gène | ZFP64 |
| Identification du gène (NCBI) | 55734 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par affinité contre l'antigène |
| Tampon de stockage | PBS with 0.02% sodium azide and 50% glycerol |
| Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
ZFP64 (also known as ZNF338) is a member of the Krüppel C2H2-type zinc finger family. ZFP64 is a coactivator of Notch1, mediating mesenchymal cell differentiation. ZFP64 expression was up-regulated in mouse peritoneal macrophages in response to stimulation with the TLR4 ligand LPS with a 2-fold increase. The MLL gene encoding the MLL fusion protein is easily activated by ZFP64. ZFP64 is essential for the continuous production of MLL fusion proteins in blood cancer and produces more cancer cells. Since ZFP64 deletion completely and specifically inhibits MLL fusion protein production and leukemia cascade growth, it is an ideal drug target.
Protocole
| Product Specific Protocols | |
|---|---|
| WB protocol for ZFP64 antibody 17187-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
| Species | Application | Title |
|---|---|---|
Cancer Cell A Transcription Factor Addiction in Leukemia Imposed by the MLL Promoter Sequence. | ||
Nat Neurosci Neuronal activity rapidly reprograms dendritic translation via eIF4G2:uORF binding | ||
Biol Direct ZFP64 drives glycolysis-mediated stem cell-like properties and tumorigenesis in breast cancer | ||
J Transl Med Cancer-associated fibroblasts promote doxorubicin resistance in triple-negative breast cancer through enhancing ZFP64 histone lactylation to regulate ferroptosis |

